BVF Partners

Venture Capital Active United States
Last updated 2026-06-18
Portfolio
2
in our dataset
Rounds participated
2
Rounds led
1
Rounds' value
$56.1M
total disclosed, rounds participated
Stages
—

Portfolio · 2

KAHR Medical
Fusion Proteins for Treating Cancer and Autoimmune Diseases
1 round $46.5M committed Latest: 2021-06
BiolineRx
Oncology Therapeutic Pharmaceutical Candidates
Led ★ 1 round $9.6M committed Latest: 2017-07

Investment activity

Portfolio by sector

Health Tech & Life Sciences2

Q&A

What is BVF Partners' primary investment focus?
BVF Partners primarily focuses on the Health Tech & Life Sciences sector, with all of its known portfolio companies operating in this area.
Can you name some of BVF Partners' portfolio companies?
BVF Partners' portfolio includes BiolineRx, which develops oncology therapeutic pharmaceutical candidates, and KAHR Medical, focused on fusion proteins for treating cancer and autoimmune diseases.
What is the typical investment range for BVF Partners?
BVF Partners typically invests between $9.6M and $46.5M per round.
When did BVF Partners make its most recent known investment?
BVF Partners made a known investment in June 2021.
What was BVF Partners' earliest known investment?
BVF Partners' earliest known investment occurred in July 2017.